Genmab — Januar 2018
-
MAIA godkendelse i slutningen af 2018 / starten af 2019
-
Alcyone bliver vel godkendt i H1-2018 til Europa formoder jeg og herefter row ? eller hvad er markedet for Alcyone 1 line nu når det ikke er USA kunne man forestille sig der er andre lande som ikke vil benytte alcyone ? men det er vel ikke noget som kommer bag på analytikerne
-
Godmorgen
-
on cost effectiveness https://www.curetoday.com/articles/despite-clinical-efficacy-only-certain-myeloma-treatments-are-cost-effective - https://peoplebeatingcancer.org/multiple-myeloma-are-darzalex-and-farydak-the-most-cost-effective/ - and the article, best to click on pdf - https://www.jmcp.org/doi/full/10.18553/jmcp.2018.24.1.29
-
Phillipe Moreau bekendtgjorde på ASH 17 at han ville fremlægge Cassiopeia på ASH 18. Det ville han ikke sige fra talerstolen, hvis han ikke var sikker. Dvs Cassiopeia-data ligger ligger klar senest august i år. Ellers kan det ikke nås.Winkel har flere gange sagt Maia i midten af 2018. Derfor regner jeg med at vi får Cass og Maia data lige oven i hinanden.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind